Ascendis Pharma (ASND) has released an update.
Ascendis Pharma A/S, a pharmaceutical company, has outlined its capital structure and share issuance policies in its updated Articles of Association. The company’s share capital stands fully paid at DKK 58,231,484, with provisions for issuing warrants and convertible bonds to directors, key employees, and advisors without preemptive rights for existing shareholders. These financial instruments are aimed at developing medical solutions for disease combat and may lead to capital increases through exercises of warrants or bond conversions, under specified conditions by the Board of Directors.
For further insights into ASND stock, check out TipRanks’ Stock Analysis page.